# Title

 Food and Drugs. PART 874â€”EAR, NOSE, AND THROAT DEVICES


# ID

 CFR-2018-title21-vol8.Pt. 874


# Structured Analysis Summary

| Type        | Values                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|:------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Constraints | ['within', 'before', 'after', 'maximum']                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Condition   | ['if', 'where', 'subject to', 'when', 'unless']                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Entities    | ['Electroglottograph', 'Mediastinoscope', 'Argon', 'Bone', 'Esophagoscope', 'Meniere', 'Otoscope', 'Endolymphatic', 'Toynbee', 'Total', 'Prosthesis', 'Epistaxis', 'Bronchoscope', 'Acoustic', 'Nasopharyngoscope', 'Partial', 'Sacculotomy', 'Eustachian', 'Ear', 'Short', 'Tinnitus', 'Scope', 'Food', 'Standards', 'Industry and FDA', 'Master', 'Laryngeal', 'Tympanic', 'Electronic', 'Wireless', 'Middle', 'Nasal', 'Guidance', 'Nasopharyngeal', 'Laryngostroboscope', 'Tympanostomy', 'Intranasal', 'Amplified'] |
| Date        | ['1996-06-01', '1999-07-13', '1976-05-28']                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |


# Structured Analysis With Context

 


## Constraints

| Constraints   | Context                                                                                                                                         |
|:--------------|:------------------------------------------------------------------------------------------------------------------------------------------------|
| after         | III (premarket approval) shall not be commercially distributed after the date shown in the regulation classifying the                           |
| before        | Before FDA requires that a device commercially distributed before the enactment date of the amendments, or a                                    |
| before        | Before FDA requires that a device commercially distributed before the enactment date of the amendments, or a                                    |
| after         | the grace period ending on the 90th day after its promulgation or on the last day of                                                            |
| after         | the grace period ending on the 90th day after its promulgation or on the last day of                                                            |
| after         | equivalent, device introduced into commercial distribution on or after May 28, 1976, including a device formerly marketed                       |
| before        | or declaring completed a PDP for the device before the device is commercially distributed unless it is                                          |
| before        | an approval under section 515 of the act before  commercial distribution.                                                                       |
| within        | or reasonably foreseeable characteristics of commercially distributed devices within that generic type or, in the case of                       |
| before        | must still submit a premarket notification to FDA before introducing or delivering for introduction into interstate commerce                    |
| maximum       | detailed summary of the device technical parameters, including maximum allowed inflation pressure, allowable catheter geometries, and available |
| after         | It is placed in the nasal cavity  after  surgery or trauma.                                                                                     |
| before        | with the Food and Drug Administration on or before July 13, 1999 for any suction antichoke device                                               |
| before        | with the Food and Drug Administration on or before July 13, 1999 for any suction antichoke device                                               |
| before        | with the Food and Drug Administration on or before July 13, 1999 for any suction antichoke device                                               |
| before        | with the Food and Drug Administration on or before July 13, 1999 for any suction antichoke device                                               |
| before        | approved PMA or declared completed PDP in effect before  being placed in commercial distribution.                                               |
| before        | with the Food and Drug Administration on or before July 13, 1999 for any tongs antichoke device                                                 |
| before        | with the Food and Drug Administration on or before July 13, 1999 for any tongs antichoke device                                                 |
| before        | with the Food and Drug Administration on or before July 13, 1999 for any tongs antichoke device                                                 |
| before        | with the Food and Drug Administration on or before July 13, 1999 for any tongs antichoke device                                                 |
| before        | approved PMA or declared completed PDP in effect before  being placed in commercial distribution.                                               |


## Condition

| Condition   | Context                                                                                                                                    |
|:------------|:-------------------------------------------------------------------------------------------------------------------------------------------|
| subject to  | of every device that is, or will be, subject to  the regulation.                                                                           |
| unless      | Regulations are to chapter I of title 21 unless  otherwise noted.                                                                          |
| unless      | date shown in the regulation classifying the device unless the manufacturer has an approval under section 515                              |
| unless      | Accordingly,  unless an effective date of the requirement for premarket                                                                    |
| unless      | the device before the device is commercially distributed unless  it is reclassified.                                                       |
| where       | or the device is intended for lay use where the former intended use was by health care                                                     |
| when        | into interstate commerce for commercial distribution the device when : (a) The device is intended for a                                    |
| if          | the device is exempt from the premarket not if ication procedures in subpart E of part 807                                                 |
| subject to  | National Standard Institute S3.6-1996, &#8220;Specification for Audiometers,&#8221; and subject to  the limitations in &#167;&#8201;874.9. |
| subject to  | subpart E of part 807 of this chapter subject to  the limitations in &#167;&#8201;874.9.                                                   |
| subject to  | subpart E of part 807 of this chapter subject to  &#167;&#8201;874.9.                                                                      |
| subject to  | subpart E of part 807 of this chapter subject to  the limitations in &#167;&#8201;874.9.                                                   |
| subject to  | subpart E of part 807 of this chapter subject to  &#167;&#8201;874.9.                                                                      |
| subject to  | subpart E of part 807 of this chapter subject to  &#167;&#8201;874.9.                                                                      |
| subject to  | subpart E of part 807 of this chapter subject to  the limitations in &#167;&#8201;874.9.                                                   |
| subject to  | subpart E of part 807 of this chapter subject to  &#167;&#8201;874.9.                                                                      |
| subject to  | subpart E of part 807 of this chapter subject to  &#167;&#8201;874.9.                                                                      |
| subject to  | subpart E of part 807 of this chapter subject to  &#167;&#8201;874.9.                                                                      |
| subject to  | subpart E of part 807 of this chapter subject to  &#167;&#8201;874.9.                                                                      |
| if          | that includes: (A) A patient card that ident if ies                                                                                        |
| subject to  | subpart E of part 807 of this chapter subject to  the limitations in &#167;&#8201;874.9.                                                   |
| subject to  | subpart E of part 807 of this chapter subject to  &#167;&#8201;874.9.                                                                      |
| where       | of the endolymphatic system into the mastoid cavity where  resorption occurs.                                                              |
| subject to  | subpart E of part 807 of this chapter subject to  the limitations in &#167;&#8201;874.9.                                                   |
| subject to  | subpart E of part 807 of this chapter subject to  &#167;&#8201;874.9.                                                                      |
| subject to  | subpart E of part 807 of this chapter subject to  the limitations in &#167;&#8201;874.9.                                                   |
| subject to  | subpart E of part 807 of this chapter subject to  the limitations in &#167;&#8201;874.9.                                                   |
| subject to  | subpart E of part 807 of this chapter subject to  the limitations in &#167;&#8201;874.9.                                                   |
| subject to  | subpart E of part 807 of this chapter subject to  &#167;&#8201;874.9.                                                                      |
| subject to  | subpart E of part 807 of this chapter subject to  the limitations in &#167;&#8201;874.9.                                                   |
| subject to  | subpart E of part 807 of this chapter subject to the limitations in &#167;&#8201;874.9 only when used in                                   |
| when        | chapter subject to the limitations in &#167;&#8201;874.9 only when  used in the external ear canal.                                        |
| subject to  | subpart E of part 807 of this chapter subject to  the limitations in &#167;&#8201;874.9.                                                   |
| subject to  | subpart E of part 807 of this chapter subject to  the limitations in &#167;&#8201;874.9.                                                   |
| subject to  | subpart E of part 807 of this chapter subject to  the limitations in &#167;&#8201;874.9.                                                   |
| subject to  | subpart E of part 807 of this chapter subject to  &#167;&#8201;874.9.                                                                      |
| subject to  | subpart E of part 807 of this chapter subject to  &#167;&#8201;874.9.                                                                      |
| subject to  | subpart E of part 807 of this chapter subject to  the limitations in &#167;&#8201;874.9.                                                   |
| when        | is a device that electronically generates a noise when  activated or                                                                       |
| when        | is a device that electronically generates a noise when  activated or                                                                       |
| subject to  | subpart E of part 807 of this chapter subject to  &#167;&#8201;874.9.                                                                      |


## Entities

| Entities           | Context                                                                                                                                          |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------|
| Food               | Food  and Drugs.                                                                                                                                 |
| Scope              | Scope .                                                                                                                                          |
| Acoustic           | Acoustic  chamber for audiometric testing.                                                                                                       |
| Short              | Short  increment sensitivity index (SISI) adapter.                                                                                               |
| Standards          | with calibration traceable to the National Bureau of Standards , oscillators, frequency counters, microphone amplifiers, and a                   |
| Electronic         | Electronic  noise generator for audiometric testing.                                                                                             |
| Electroglottograph | Electroglottograph .                                                                                                                             |
| Toynbee            | Toynbee  diagnostic tube.                                                                                                                        |
| Wireless           | Wireless  air-conduction hearing aid.                                                                                                            |
| Tympanic           | Tympanic  membrane contact hearing aid.                                                                                                          |
| Amplified          | Amplified sound is transmitted by vibrating the tympanic membrane                                                                                |
| Master             | Master  hearing aid.                                                                                                                             |
| Tinnitus           | Tinnitus  masker.                                                                                                                                |
| Middle             | Middle  ear mold.                                                                                                                                |
| Partial            | Partial  ossicular replacement prosthesis.                                                                                                       |
| Total              | Total  ossicular replacement prosthesis.                                                                                                         |
| Prosthesis         | Prosthesis  modification instrument for ossicular replacement surgery.                                                                           |
| Ear                | Ear , nose, and throat synthetic polymer material.                                                                                               |
| Ear                | Ear , nose, and throat synthetic polymer material is                                                                                             |
| Laryngeal          | Laryngeal  prosthesis (Taub design).                                                                                                             |
| Sacculotomy        | Sacculotomy  tack (Cody tack) (a) Identification.                                                                                                |
| Endolymphatic      | Endolymphatic  shunt.                                                                                                                            |
| Endolymphatic      | Endolymphatic  shunt tube with valve.                                                                                                            |
| Meniere            | to endolymphatic hydrops (increase in endolymphatic fluid) of Meniere 's disease.                                                                |
| Guidance           | the FDA guidance document &#8220;Class II Special Controls Guidance  Document: Endolymphatic Shunt Tube With Valve;                              |
| Industry and FDA   | Document: Endolymphatic Shunt Tube With Valve; Guidance for Industry and FDA .&#8221;                                                            |
|                    |               Tympanostomy tube.                                                                                                                 |
| Tympanostomy       | Tube With Valve; Guidance for Industry and FDA.&#8221; Tympanostomy  tube.                                                                       |
| Nasal              | Nasal  dilator.                                                                                                                                  |
| Tympanostomy       | Tympanostomy  tube with semipermeable membrane.                                                                                                  |
| Guidance           | FDA's guidance document entitled &#8220;Class II Special Controls Guidance  Document: Transcutaneous Air Conduction Hearing Aid System (TACHAS); |
| Industry and FDA   | Air Conduction Hearing Aid System (TACHAS); Guidance for Industry and FDA .&#8221; See &#167;&#8201;874.1 for the availability of this           |
| Epistaxis          | Epistaxis  balloon.                                                                                                                              |
| Ear                | Ear , nose, and throat bur.                                                                                                                      |
| Nasopharyngeal     | Nasopharyngeal  catheter.                                                                                                                        |
| Eustachian         | Eustachian  tube balloon dilation system.                                                                                                        |
| Eustachian         | A  Eustachian tube balloon dilation system is a prescription device                                                                              |
| Eustachian         | use in dilating the cartilaginous portion of the Eustachian  tube for treating persistent                                                        |
| Eustachian         | use in dilating the cartilaginous portion of the Eustachian  tube for treating persistent                                                        |
| Eustachian         | access to only the cartilaginous portion of the Eustachian  tube.                                                                                |
| Ear                | Ear , nose, and throat electric or pneumatic surgical                                                                                            |
| Ear                | Ear , nose, and throat fiberoptic light source and                                                                                               |
| Ear                | Ear , nose, and throat manual surgical instrument.                                                                                               |
| Argon              | Argon  laser for otology, rhinology, and laryngology.                                                                                            |
| Ear                | Ear , nose, and throat microsurgical carbon dioxide laser.                                                                                       |
| Bronchoscope       | Bronchoscope  (flexible or rigid) and accessories.                                                                                               |
| Esophagoscope      | Esophagoscope  (flexible or rigid) and accessories.                                                                                              |
| Mediastinoscope    | Mediastinoscope  and accessories.                                                                                                                |
| Laryngostroboscope | Laryngostroboscope .                                                                                                                             |
| Nasopharyngoscope  | Nasopharyngoscope  (flexible or rigid) and accessories.                                                                                          |
| Otoscope           | Otoscope .                                                                                                                                       |
| Intranasal         | Intranasal  splint.                                                                                                                              |
| Bone               | Bone  particle collector.                                                                                                                        |
| Ear                | Ear , nose, and throat drug administration device.                                                                                               |
| Ear                | Ear , nose, and throat examination and treatment unit.                                                                                           |


## Date

| Date       | Context                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|:-----------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 1976-05-28 | (b) Any new, not substantially equivalent, device introduced into commercial distribution on or after May 28, 1976, including a device formerly marketed that has been substantially altered, is classified by statute (section 513(f) of the act) into class III without any grace period and FDA must have issued an order approving a PMA or declaring completed a PDP for the device before the device is commercially distributed unless it is reclassified. |
| 1976-05-28 | Accordingly, the regulation for such a class III device states that as of the enactment date of the amendments, May 28, 1976, the device must have an approval under section 515 of the act before commercial distribution.                                                                                                                                                                                                                                       |
| 1996-06-01 | Except for the otoacoustic emission device, the device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter, if it is in compliance with American National Standard Institute S3.6-1996, &#8220;Specification for Audiometers,&#8221; and subject to the limitations in &#167;&#8201;874.9.                                                                                                                              |
| 1999-07-13 | A PMA or a notice of completion of a PDP for a device is required to be filed with the Food and Drug Administration on or before July 13, 1999 for any suction antichoke device that was in commercial distribution before May 28, 1976, or that has, on or before July 13, 1999, been found to be substantially equivalent to a suction antichoke device that was in commercial distribution before May 28, 1976.                                                |
| 1976-05-28 | A PMA or a notice of completion of a PDP for a device is required to be filed with the Food and Drug Administration on or before July 13, 1999 for any suction antichoke device that was in commercial distribution before May 28, 1976, or that has, on or before July 13, 1999, been found to be substantially equivalent to a suction antichoke device that was in commercial distribution before May 28, 1976.                                                |
| 1999-07-13 | A PMA or a notice of completion of a PDP for a device is required to be filed with the Food and Drug Administration on or before July 13, 1999 for any suction antichoke device that was in commercial distribution before May 28, 1976, or that has, on or before July 13, 1999, been found to be substantially equivalent to a suction antichoke device that was in commercial distribution before May 28, 1976.                                                |
| 1976-05-28 | A PMA or a notice of completion of a PDP for a device is required to be filed with the Food and Drug Administration on or before July 13, 1999 for any suction antichoke device that was in commercial distribution before May 28, 1976, or that has, on or before July 13, 1999, been found to be substantially equivalent to a suction antichoke device that was in commercial distribution before May 28, 1976.                                                |
| 1999-07-13 | A PMA or a notice of completion of a PDP for a device is required to be filed with the Food and Drug Administration on or before July 13, 1999 for any tongs antichoke device that was in commercial distribution before May 28, 1976, or that has, on or before July 13, 1999, been found to be substantially equivalent to a tongs antichoke device that was in commercial distribution before May 28, 1976.                                                    |
| 1976-05-28 | A PMA or a notice of completion of a PDP for a device is required to be filed with the Food and Drug Administration on or before July 13, 1999 for any tongs antichoke device that was in commercial distribution before May 28, 1976, or that has, on or before July 13, 1999, been found to be substantially equivalent to a tongs antichoke device that was in commercial distribution before May 28, 1976.                                                    |
| 1999-07-13 | A PMA or a notice of completion of a PDP for a device is required to be filed with the Food and Drug Administration on or before July 13, 1999 for any tongs antichoke device that was in commercial distribution before May 28, 1976, or that has, on or before July 13, 1999, been found to be substantially equivalent to a tongs antichoke device that was in commercial distribution before May 28, 1976.                                                    |
| 1976-05-28 | A PMA or a notice of completion of a PDP for a device is required to be filed with the Food and Drug Administration on or before July 13, 1999 for any tongs antichoke device that was in commercial distribution before May 28, 1976, or that has, on or before July 13, 1999, been found to be substantially equivalent to a tongs antichoke device that was in commercial distribution before May 28, 1976.                                                    |


